Live from the NIH registry
Studies recruiting near Waco right now
Top 25 of 53 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NextStage Clinical Research — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
ActiveTherapy Alliance — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Waco, Texas (2.6 mi)
· Sponsor: AstraZeneca
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Velocity Clinical Research — Waco, Texas (2.6 mi)
· Sponsor: Janssen Research & Development, LLC
Alleviant ALLAY-HF Study
Heart Failure
N/A
Interventional 700 participants sought
Waco Cardiology — Waco, Texas (2.6 mi)
· Sponsor: Alleviant Medical, Inc.
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology- Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - Central/South Texas — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Vor Biopharma
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Primary Biliary Cholangitis, PBC
Phase 2
Interventional 260 participants sought
Impact Research — Waco, Texas (2.6 mi)
· Sponsor: Mirum Pharmaceuticals, Inc.
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 8618 — Waco, Texas (2.6 mi)
· Sponsor: Galderma R&D
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: Akero Therapeutics, Inc
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Cancer
N/A
Observational 10,000 participants sought
Baylor Scott & White Medical Center - Hillcrest — Waco, Texas (2.6 mi)
· Sponsor: Baylor Research Institute
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 1
Interventional 350 participants sought
USOR - Texas Oncology - (DFW) Waco — Waco, Texas (2.6 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2, Phase 3
Interventional 650 participants sought
Site #0152 — Waco, Texas (2.6 mi)
· Sponsor: Bicara Therapeutics
Reliability and Validity of the PReFS
Neurologic Disorders, Spinal Cord Injury
N/A
Observational 15 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Waco, Texas (2.6 mi)
· Sponsor: Alnylam Pharmaceuticals
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Nextstage Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 3
Interventional 500 participants sought
Texas Oncology-Central South — Waco, Texas (2.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Computerized Depression Intervention in Veterans
Depression
N/A
Interventional 152 participants sought
Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX — Waco, Texas (2.6 mi)
· Sponsor: VA Office of Research and Development